300009.SZ
安科生物
SZSE · Healthcare · C 制造业 · CN
CNY 8.49
−5.35%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
14.6x
Market Cap
CNY 14.18B
MomentumView details →
1D Return
−5.35%
YTD Return
−13.06%
RSI (14)
46.0
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
14.6x
Market Cap
CNY 14.18B
RSI (14)
46.0
MomentumView details →
1D Return
−5.35%
YTD Return
−13.06%
Similar companies
Latest newsMore news →
Anke Bio announced it will acquire the remaining 27.4647% equity in Anke Yuliangqing from several shareholders for 54.3238 million yuan, making it a wholly-owned subsidiary.7d agoAnke Bio announced its first-half 2026 results: revenue of 1.098 billion yuan, down 15.04% year-on-year; net profit attributable to shareholders of 332 million yuan, down 9.33% year-on-year; and no dividend or share transfer plan.10d ago